Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease

BACKGROUND: Twenty-four-hour treatment options could provide a continuous drug delivery strategy in advanced Parkinson’s disease and can ameliorate motor and non-motor complications. Use of levodopa infusion is often limited to 12–16 h/day due to its cost. Adjunctive overnight rotigotine transdermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Yue Hui, Leta, Valentina, Rukavina, Katarina, Parry, Miriam, Ann Natividad, Jenny, Metta, Vinod, Chung-Faye, Guy, Chaudhuri, K. Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217845/
https://www.ncbi.nlm.nih.gov/pubmed/35503480
http://dx.doi.org/10.1007/s00702-022-02506-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217845/
https://www.ncbi.nlm.nih.gov/pubmed/35503480
http://dx.doi.org/10.1007/s00702-022-02506-4

Ejemplares similares